Company news
enGene Holdings Inc. news in 2025
enGene Holdings Inc.'s news releases, calls and decks from 2025, newest first.
enGene Reports Full Year 2025 Financial Results and Provides Business Update
December 22, 2025
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors
December 16, 2025
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
December 2, 2025
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
November 13, 2025
enGene Announces Proposed Public Offering of Common Shares
November 12, 2025
Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
November 11, 2025
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
November 10, 2025
enGene Named a BioSpace 2026 Best Places to Work Winner
November 4, 2025